867611000001105: Temgesic 200microgram sublingual tablets (Schering-Plough Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)
\UK product\Virtual medicinal product\Product containing precisely buprenorphine (as buprenorphine hydrochloride) 200 microgram/1 each conventional release sublingual tablet\Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)
\UK product\Virtual therapeutic moiety\Buprenorphine\Product containing only buprenorphine in oromucosal dose form (medicinal product form)\Product containing precisely buprenorphine (as buprenorphine hydrochloride) 200 microgram/1 each conventional release sublingual tablet\Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)
\UK product\Virtual therapeutic moiety\Buprenorphine\Product containing precisely buprenorphine (as buprenorphine hydrochloride) 200 microgram/1 each conventional release sublingual tablet\Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)
\UK product\Trade family\Temgesic\Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)

\Medicinal product\Product containing plant material (product)\Product containing phytochemical\Product containing buprenorphine\Buprenorphine\Product containing only buprenorphine in oromucosal dose form (medicinal product form)\Product containing precisely buprenorphine (as buprenorphine hydrochloride) 200 microgram/1 each conventional release sublingual tablet\Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)
\Medicinal product\Product containing plant material (product)\Product containing phytochemical\Product containing buprenorphine\Buprenorphine\Product containing precisely buprenorphine (as buprenorphine hydrochloride) 200 microgram/1 each conventional release sublingual tablet\Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)
\Medicinal product\Product containing plant material (product)\Product containing phytochemical\Product containing buprenorphine\Product containing buprenorphine in oromucosal dose form (medicinal product form)\Product containing only buprenorphine in oromucosal dose form (medicinal product form)\Product containing precisely buprenorphine (as buprenorphine hydrochloride) 200 microgram/1 each conventional release sublingual tablet\Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)
\Medicinal product\Product containing plant material (product)\Product containing plant agent\Product containing buprenorphine\Buprenorphine\Product containing only buprenorphine in oromucosal dose form (medicinal product form)\Product containing precisely buprenorphine (as buprenorphine hydrochloride) 200 microgram/1 each conventional release sublingual tablet\Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)
\Medicinal product\Product containing plant material (product)\Product containing plant agent\Product containing buprenorphine\Buprenorphine\Product containing precisely buprenorphine (as buprenorphine hydrochloride) 200 microgram/1 each conventional release sublingual tablet\Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)
\Medicinal product\Product containing plant material (product)\Product containing plant agent\Product containing buprenorphine\Product containing buprenorphine in oromucosal dose form (medicinal product form)\Product containing only buprenorphine in oromucosal dose form (medicinal product form)\Product containing precisely buprenorphine (as buprenorphine hydrochloride) 200 microgram/1 each conventional release sublingual tablet\Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)
\Medicinal product\Product manufactured as oromucosal dose form\Product containing buprenorphine in oromucosal dose form (medicinal product form)\Product containing only buprenorphine in oromucosal dose form (medicinal product form)\Product containing precisely buprenorphine (as buprenorphine hydrochloride) 200 microgram/1 each conventional release sublingual tablet\Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing opioid receptor agonist\Product containing opioid receptor partial agonist\Product containing buprenorphine\Buprenorphine\Product containing only buprenorphine in oromucosal dose form (medicinal product form)\Product containing precisely buprenorphine (as buprenorphine hydrochloride) 200 microgram/1 each conventional release sublingual tablet\Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing opioid receptor agonist\Product containing opioid receptor partial agonist\Product containing buprenorphine\Buprenorphine\Product containing precisely buprenorphine (as buprenorphine hydrochloride) 200 microgram/1 each conventional release sublingual tablet\Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing opioid receptor agonist\Product containing opioid receptor partial agonist\Product containing buprenorphine\Product containing buprenorphine in oromucosal dose form (medicinal product form)\Product containing only buprenorphine in oromucosal dose form (medicinal product form)\Product containing precisely buprenorphine (as buprenorphine hydrochloride) 200 microgram/1 each conventional release sublingual tablet\Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing alkaloid\Product containing naturally occurring alkaloid\Product containing buprenorphine\Buprenorphine\Product containing only buprenorphine in oromucosal dose form (medicinal product form)\Product containing precisely buprenorphine (as buprenorphine hydrochloride) 200 microgram/1 each conventional release sublingual tablet\Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing alkaloid\Product containing naturally occurring alkaloid\Product containing buprenorphine\Buprenorphine\Product containing precisely buprenorphine (as buprenorphine hydrochloride) 200 microgram/1 each conventional release sublingual tablet\Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing alkaloid\Product containing naturally occurring alkaloid\Product containing buprenorphine\Product containing buprenorphine in oromucosal dose form (medicinal product form)\Product containing only buprenorphine in oromucosal dose form (medicinal product form)\Product containing precisely buprenorphine (as buprenorphine hydrochloride) 200 microgram/1 each conventional release sublingual tablet\Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

16993501000001114 Temgesic 200microgram sublingual tablets (Schering-Plough Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
16993601000001113 Temgesic 200microgram sublingual tablets (Schering-Plough Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
63815301000001111 Temgesic 200microgram sublingual tablets (RB Pharmaceuticals Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
103892001000001119 Temgesic 200microgram sublingual tablets (Indivior UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)	Is a	Product containing precisely buprenorphine (as buprenorphine hydrochloride) 200 microgram/1 each conventional release sublingual tablet	true	Inferred relationship	Existential restriction modifier
Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category Schedule 3 (CD No Register)	true	Inferred relationship	Existential restriction modifier
Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)	Has NHS dm+d (dictionary of medicines and devices) freeness indicator	Sugar free	true	Inferred relationship	Existential restriction modifier
Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)	Has excipient	Lactose	false	Inferred relationship	Existential restriction modifier
Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)	Has active ingredient	Buprenorphine hydrochloride	false	Inferred relationship	Existential restriction modifier
Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)	Has active ingredient	Opiate agonist-antagonist	false	Inferred relationship	Existential restriction modifier
Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)	Has active ingredient	Substance with opioid receptor partial agonist mechanism of action	false	Inferred relationship	Existential restriction modifier
Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)	Has active ingredient	Buprenorphine	false	Inferred relationship	Existential restriction modifier
Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)	Has manufactured dose form	Conventional release sublingual tablet	true	Inferred relationship	Existential restriction modifier
Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)	Is a	Temgesic	true	Inferred relationship	Existential restriction modifier
Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Buprenorphine	true	Inferred relationship	Existential restriction modifier
Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)	Has specific active ingredient	Buprenorphine hydrochloride	true	Inferred relationship	Existential restriction modifier
Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)	Has dispensed dose form	Conventional release sublingual tablet	true	Inferred relationship	Existential restriction modifier
Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)	Has basis of strength substance	Buprenorphine	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Temgesic 200microgram sublingual tablets (Schering-Plough Ltd) 50 tablet 5 x 10 tablets	Is pack of	False	Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)	Inferred relationship	Existential restriction modifier
Temgesic 200microgram sublingual tablets (Schering-Plough Ltd) 50 tablet 5 x 10 tablets	Has AMP	True	Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
16993501000001114	Temgesic 200microgram sublingual tablets (Schering-Plough Ltd) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
16993601000001113	Temgesic 200microgram sublingual tablets (Schering-Plough Ltd)	en	Synonym	Inactive	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
63815301000001111	Temgesic 200microgram sublingual tablets (RB Pharmaceuticals Ltd)	en	Synonym	Inactive	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
103892001000001119	Temgesic 200microgram sublingual tablets (Indivior UK Ltd)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module